Literature DB >> 20936365

[Sentinel lymph node biopsy in breast cancer].

Gero Luschin1.   

Abstract

Complete axillary lymph node dissection has been the traditional operation to determine whether cancer has spread beyond the breast. In the large majority of patients with breast cancer, lymphatic mapping and γ-probe-guided and/or blue dye sentinel node biopsy can be used to locate the first node in the axilla, and thereby provide important information about the status of axillary nodes. Patients without clinical involvement of the axilla should undergo sentinel node biopsy routinely. Thus, they may be spared complete axillary dissection if the sentinel node is negative. Decreased arm swelling and pain are associated with sentinel lymph node biopsy compared with axillary lymph node dissection.

Entities:  

Mesh:

Year:  2010        PMID: 20936365     DOI: 10.1007/s10354-010-0830-1

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  19 in total

1.  Sentinel node localization in breast cancer patients using intradermal dye injection.

Authors:  L Ilum; M Bak; K E Olsen; D Kryh; V Berg; C K Axelsson
Journal:  Acta Oncol       Date:  2000       Impact factor: 4.089

2.  Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer.

Authors:  C Lanng; J Hoffmann; H Galatius; U Engel
Journal:  Eur J Surg Oncol       Date:  2006-11-03       Impact factor: 4.424

3.  Clinical assessment of lymph nodes in carcinoma of the breast.

Authors:  S J Cutler; L M Axtell; D Schottenfeld; J H Farrow
Journal:  Surg Gynecol Obstet       Date:  1970-07

4.  Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.

Authors:  U Veronesi; G Paganelli; V Galimberti; G Viale; S Zurrida; M Bedoni; A Costa; C de Cicco; J G Geraghty; A Luini; V Sacchini; P Veronesi
Journal:  Lancet       Date:  1997-06-28       Impact factor: 79.321

5.  Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer.

Authors:  F W van der Ent; R A Kengen; H A van der Pol; A G Hoofwijk
Journal:  Eur J Surg Oncol       Date:  1999-02       Impact factor: 4.424

6.  Sentinel node biopsy in breast cancer: ALMANAC trial.

Authors:  D Clarke; N I Khonji; R E Mansel
Journal:  World J Surg       Date:  2001-05-14       Impact factor: 3.352

7.  Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer.

Authors:  R de Freitas; M V Costa; S V Schneider; M A Nicolau; E Marussi
Journal:  Eur J Surg Oncol       Date:  1991-06       Impact factor: 4.424

8.  Micrometastases or isolated tumor cells and the outcome of breast cancer.

Authors:  Maaike de Boer; Carolien H M van Deurzen; Jos A A M van Dijck; George F Borm; Paul J van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen
Journal:  N Engl J Med       Date:  2009-08-13       Impact factor: 91.245

9.  Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings.

Authors:  R A Sacre
Journal:  Eur J Surg Oncol       Date:  1986-06       Impact factor: 4.424

10.  Role of ultrasonography to detect axillary node involvement in operable breast cancer.

Authors:  J S Vaidya; J J Vyas; M H Thakur; K C Khandelwal; I Mittra
Journal:  Eur J Surg Oncol       Date:  1996-04       Impact factor: 4.424

View more
  1 in total

1.  Distinct Ezrin Truncations Differentiate Metastases in Sentinel Lymph Nodes from Unaffected Lymph Node Tissues, from Primary Breast Tumors, and from Healthy Glandular Breast Tissues.

Authors:  Claudia Röwer; Christian George; Toralf Reimer; Bernd Stengel; Anngret Radtke; Bernd Gerber; Michael O Glocker
Journal:  Transl Oncol       Date:  2017-11-10       Impact factor: 4.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.